BakBone NetVault: Backup Proves Invaluable For Cancer Research UK
Main Category: IT / Internet / E-mailArticle Date: 13 Mar 2008 - 1:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
BakBone Software® (Pink Sheets:BKBO), the leading provider of heterogeneous integrated data protection solutions, announced that Cancer Research UK has dramatically improved storage administration and data protection levels by consolidating 40TB of data with BakBone's NetVault®: Backup. Employing more than 4,250 scientists, doctors and nurses throughout the UK, this is the world's leading independent organization dedicated to cancer research. Cancer Research UK relies on BakBone to backup two storage area networks (SANs) and several Mac and Linux servers at its Cambridge and London facilities.
The Cancer Research UK data storage infrastructure includes two Apple XSANs, one located at the Cambridge Research Institute and the other at the London Research Institute, both backed up to tape libraries across an optical fibre. These SANs are used predominantly by Mac users for storing scientific research data, including large volumes of AVI and MPG files, which are served to users via Gigabit Ethernet connections from Mac Xserves servers acting as SAN clients.
"With so much data to manage and protect 24/7, ease of use is of paramount importance for us both in terms of configuration and day-to-day administration. BakBone's reporting tools and policy management have been highly effective in helping us achieve this," said William Harris, technical solutions architect, Cancer Research UK. "BakBone NetVault: Backup has allowed us to consolidate our data protection strategy, saving us man hours, increasing data protection and giving us piece of mind. It has been invaluable."
"Before the deployment of NetVault: Backup, the Cancer Research UK's IT department relied on separate backup solutions, making the data protection set up time consuming and inefficient," said Chris Ross, VP of EMEA, BakBone. "BakBone provided a practical and affordable solution for the organization's Mac environment that set us apart from the competition."
After evaluating a number of options, Cancer Research UK selected BakBone software because of its blend of high performance solutions, post-sales Mac support and price; being a charity the organization has an obligation to keep costs to a minimum without compromising quality. Over the coming months the charity will look at leveraging NetVault: Backup to protect Oracle and MySQL data with BakBone Application Plugin Modules™.
About BakBone Software, Inc.
BakBone is committed to making data protection a simple, straightforward process while delivering its Integrated Data Protection (IDP) strategy through an award-winning product suite. This suite provides unprecedented capabilities not only to protect critical data - but more importantly, to ensure the availability of that data as well. BakBone's products offer a single point of control for managing resources across all platforms, providing improved operational efficiency, reduced system downtime, improved availability and enhanced security to support the business growth of enterprise environments. Thousands of users worldwide leverage BakBone's IDP approach to simplify the management of multi-platform environments with a portfolio of backup, disaster recovery, replication and storage reporting solutions for Linux, Windows, Unix and Mac OS environments. These scalable data protection solutions address the demands of Global 5000 organizations and are distributed through a worldwide network of select OEM partners, strategic partners, resellers and solution providers. BakBone is headquartered in San Diego, Calif. For more information about BakBone, visit http://www.bakbone.com or email info@bakbone.com.
This press release contains forward-looking statements that involve risks, uncertainties, assumptions and other factors, which, if they do not materialise or prove correct, could cause BakBone's results to differ materially from historical results, or those expressed or implied by such forward-looking statements. The potential risks and uncertainties may include, but are not limited to: competition in our target markets; potential capital needs; management of future growth and expansion; the development, implementation and execution of the Company's Integrated Data Protection (IDP) strategic vision; risk of third-party claims of infringement; protection of proprietary information; customer acceptance of the Company's existing and newly introduced products and fee structures; and the success of BakBone's brand development efforts. Also, risks associated with strategic alliances; reliance on distribution channels; product concentration; need to develop new and enhanced products; potential product defects; our ability to hire and retain qualified employees and key management personnel; and risks associated with changes in domestic and international market conditions and the entry into and development of international markets for the Company's products. Our forward-looking statements should be considered in the context of these and other risk factors disclosed in our most recent report filed with the Securities and Exchange Commission, which may be found at http://www.sec.gov, as well as those risk factors disclosed in our current report filed with the Canadian Securities Administrators, which is available on SEDAR at http://www.sedar.com. All future written and oral forward-looking statements made by us or on our behalf are also subject to these factors. BakBone assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made, other than as required under applicable securities laws.
The common shares of BakBone are currently subject to cease trade orders in the Canadian jurisdictions of Alberta, British Columbia and Ontario due to delays in the filing of the Company's financial statements. Although these cease trade orders do not prevent investors, who are not resident in or otherwise subject to the laws of Alberta, British Columbia or Ontario, from trading the common shares of BakBone on the Pink Sheets in the United States, investors are encouraged to obtain legal advice to ensure that these trades are not violating the cease trade orders. BakBone continues to work to resolve all outstanding issues which have prevented filing of its financial statements, however an exact date for filing of these financial statements cannot be determined at this time.
BakBone®, BakBone Software®, NetVault®, Application Plugin Module™, BakBone logo®, Integrated Data Protection™, Redefining Data Protection™, Constant Data™, Constant Data logo™, Constant Replicator™, OnDemand Replicator™, and Constant HA Cluster™, are all trademarks or registered trademarks of BakBone Software, Inc., in the United States and/or in other countries. Sun, Sun Microsystems, the Sun logo, StorageTek, Solaris, and The Network is The Computer are trademarks or registered trademarks of Sun Microsystems, Inc. in the United States and other countries. All other brands, products or service names are or may be trademarks, registered trademarks or service marks of, and used to identify, products or services of their respective owners.
http://www.bakbone.com
Visit our it / internet / e-mail section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/100403.php>
APA
http://www.medicalnewstoday.com/releases/100403.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




